Tobias Gerhard

6.2k total citations · 1 hit paper
105 papers, 4.3k citations indexed

About

Tobias Gerhard is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Clinical Psychology. According to data from OpenAlex, Tobias Gerhard has authored 105 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Psychiatry and Mental health, 20 papers in Economics and Econometrics and 17 papers in Clinical Psychology. Recurrent topics in Tobias Gerhard's work include Schizophrenia research and treatment (24 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Attention Deficit Hyperactivity Disorder (18 papers). Tobias Gerhard is often cited by papers focused on Schizophrenia research and treatment (24 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Attention Deficit Hyperactivity Disorder (18 papers). Tobias Gerhard collaborates with scholars based in United States, Netherlands and Canada. Tobias Gerhard's co-authors include Mark Olfson, Stephen Crystal, Cecilia Huang, T. Scott Stroup, Almut G. Winterstein, Sebastian Schneeweiß, Melanie M. Wall, Jonathan J. Shuster, Krista F. Huybrechts and Christoph U. Correll and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Neurology.

In The Last Decade

Tobias Gerhard

103 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Premature Mortality Among Adults With Schizophrenia in the United States

2015 744 citations Mark Olfson, Tobias Gerhard et al. profile →

Peers

Countries citing papers authored by Tobias Gerhard

Since Specialization

Citations

This map shows the geographic impact of Tobias Gerhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Gerhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Gerhard more than expected).

Fields of papers citing papers by Tobias Gerhard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Gerhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Gerhard. The network helps show where Tobias Gerhard may publish in the future.

Co-authorship network of co-authors of Tobias Gerhard

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Gerhard. A scholar is included among the top collaborators of Tobias Gerhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Gerhard. Tobias Gerhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Population‐Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study 2025 ·Clinical Pharmacology & Therapeutics ·Rishi Desai, Vijay R. Varma, Mufaddal Mahesri, Su Been Lee, Arnold S. Freedman, Tobias Gerhard, Jodi B Segal, Seanna Vine, Mary B. Ritchey, Daniel B. Horton, Madhav Thambisetty	1
2	Nationwide trends in diagnosed sedative, hypnotic or anxiolytic use disorders in adolescents and young adults enrolled in Medicaid: 2001–2019 2025 ·Addiction ·Greta Bushnell, Kristen Lloyd, Mark Olfson, Tobias Gerhard, Katherine M. Keyes, Magdalena Cerdá, Deborah S. Hasin	1
3	Early Childhood Antibiotics and Chronic Pediatric Conditions: A Retrospective Cohort Study 2025 ·The Journal of Infectious Diseases ·(unknown), Soko Setoguchi, Tobias Gerhard, Jason Roy, (unknown), Dinesh Mendhe, (unknown), Brian L. Strom, Martin J. Blaser, Daniel B. Horton	0
4	Prescription opioid use and opioid use disorder among older adults with HIV in the USA from 2008 to 2021: a retrospective repeated cross-sectional study 2025 ·PubMed ·Stephanie Shiau, (unknown), Carolyn Waugh Kinkade, (unknown), Greta Bushnell, Hillary Samples, (unknown), Laura Bennett, Chintan V. Dave, Perry N. Halkitis, Tobias Gerhard, Jason Roy, Sílvia S. Martins, Michael T. Yin, Stephen Crystal	0
5	Validity of ICD‐10‐based algorithms to identify patients with influenza in inpatient and outpatient settings 2024 ·Pharmacoepidemiology and Drug Safety ·(unknown), Abner Nyandege, (unknown), Saira Jan, Soko Setoguchi, Tobias Gerhard, Brian L. Strom, Daniel B. Horton	6
6	Effects of antimicrobial exposure on the risk of Parkinson's disease 2024 ·Parkinsonism & Related Disorders ·Gian Pal, Laura Bennett, Jason Roy, Abner Nyandege, M. Maral Mouradian, Tobias Gerhard, Daniel B. Horton	3
7	Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals 2023 ·Addiction ·Greta Bushnell, Moira A. Rynn, Tobias Gerhard, Katherine M. Keyes, Deborah S. Hasin, Magdalena Cerdá, Abner Nyandege, Mark Olfson	2
8	Outpatient prescribing of opioids to adults diagnosed with mental disorders in the United States 2020 ·Drug and Alcohol Dependence ·Matthew T. Taylor, Daniel B. Horton, (unknown), Mark Olfson, Tobias Gerhard	2
9	Age and Incidence of Dementia Diagnosis 2020 ·Journal of General Internal Medicine ·Mark Olfson, T. Scott Stroup, Cecilia Huang, Melanie M. Wall, Tobias Gerhard	10
10	Comparing record linkage software programs and algorithms using real-world data 2019 ·PLoS ONE ·Alan F. Karr, Matthew T. Taylor, Suzanne L. West, Soko Setoguchi, Tzuyung D. Kou, Tobias Gerhard, Daniel B. Horton	17
11	Antipsychotic Medication Treatment Patterns in Adult Depression 2017 ·The Journal of Clinical Psychiatry ·Tobias Gerhard, T. Scott Stroup, Christoph U. Correll, Cecilia Huang, Zhiqiang Tan, Stephen Crystal, Mark Olfson	12
12	Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis 2016 ·Journal of the American Academy of Child & Adolescent Psychiatry ·(unknown), (unknown), Britta Galling, Silvia Molteni, (unknown), Stephanie H. Ameis, Tobias Gerhard, Mark Olfson, Christoph U. Correll	62
13	National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression 2014 ·The Journal of Clinical Psychiatry ·Tobias Gerhard, Ayşe Akıncıgil, Christoph U. Correll, (unknown), Stephen Crystal, Mark Olfson	34
14	Comparative mortality risks of antipsychotic medications in community-dwelling older adults 2013 ·The British Journal of Psychiatry ·Tobias Gerhard, Krista F. Huybrechts, Mark Olfson, Sebastian Schneeweiß, William V. Bobo, P. Murali Doraiswamy, Davangere P. Devanand, Judith A. Lucas, (unknown), Edmond S. Malka, Robert M. Levin, Stephen Crystal	56
15	Pre‐existing cardiovascular conditions and pharmacological treatment of adult ADHD 2010 ·Pharmacoepidemiology and Drug Safety ·Tobias Gerhard, Almut G. Winterstein, Mark Olfson, Cecilia Huang, Arwa Saidi, Stephen Crystal	15
16	Systolic Blood Pressure and Subjective Well‐Being in Patients with Coronary Artery Disease 2009 ·Clinical Cardiology ·Yan Gong, Eileen Handberg, Tobias Gerhard, Rhonda M. Cooper‐DeHoff, L. Douglas Ried, Julie A. Johnson, Carl J. Pepine	18
17	Mental Health Treatment Received by Youths in the Year Before and After a New Diagnosis of Bipolar Disorder 2009 ·Psychiatric Services ·Mark Olfson, Stephen Crystal, Tobias Gerhard, Cecilia Huang, Gabrielle A. Carlson	19
18	Determinants of Initial Pharmacological Treatment for Youths with Attention-Deficit/Hyperactivity Disorder 2009 ·Journal of Child and Adolescent Psychopharmacology ·(unknown), Tobias Gerhard, Almut G. Winterstein	39
19	Pharmacoeconomic Modeling of Nesiritide versus Dobutamine for Decompensated Heart Failure 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Tobias Gerhard, Issam Zineh, Almut G. Winterstein, Abraham G. Hartzema	6
20	Effectiveness of nesiritide on dialysis or all‐cause mortality in patients undergoing cardiothoracic surgery 2006 ·Clinical Cardiology ·Thomas M. Beaver, Almut G. Winterstein, Jonathan J. Shuster, Tobias Gerhard, Tomas D. Martin, James A. Alexander, Richard J. Johnson, Ahsan Ejaz, Abraham G. Hartzema	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact